Table 2 CKMT1A expression associated with the clinicopathological parameters of NSCLC patients
From: Mitochondrial creatine kinase 1 in non-small cell lung cancer progression and hypoxia adaptation
Clinicopathological parameters | n | CKMT1A Low (n%) | CKMT1A High (n%) | P |
|---|---|---|---|---|
Gender | ||||
Male | 20 | 5 (25) | 15 (75) | 0.131 |
Female | 12 | 7 (58.3) | 5 (41.7) | |
Age (years) | ||||
< 60 | 19 | 8 (42.1) | 11 (57.9) | 0.780 |
≥ 60 | 13 | 4 (30.8) | 9 (69.2) | |
Tumor diameter (cm) | ||||
< 5 | 15 | 7 (46.7) | 8 (53.3) | 0.522 |
≥ 5 | 17 | 5 (29.4) | 12 (70.6) | |
Pathological grade | ||||
I–II | 17 | 10 (58.8) | 7 (41.2) | 0.022* |
II–III | 15 | 2 (13.3) | 13 (86.7) | |